Benzinga's Microcap Movers for Monday August 13, 2012
Below are highlights from Benzinga's daily coverage of small cap and microcap securities making big moves:
Shares of Alexza Pharmaceuticals (NASDAQ: ALXA), the Mountain View, CA pharmaceutical company, rose 38.85% Monday on 8.5 times average volume.
A spokesperson for Alexza Pharmaceuticals to Benzinga there was no news to account for the move today.
Alexza Pharmaceuticals closed at $4.11 on Monday.
Ascent Solar Technologies
Shares of Ascent Solar Technologies (NASDAQ: ASTI), the Thornton, CO developer of solar powered materials and devices, rose 37.85% Monday on average volume.
Ascent Solar Technologies announced Monday it has launched a charger for the Samsung® Galaxy S III smart phone featuring Ascent's ultra light CIGS technology. Branded under Ascent's EnerPlex line of consumer products, the charger incorporates the company's solar cells into a sleek, protective Galaxy S III case, along with an ultra thin battery. The charger adds minimal weight and size to the Galaxy S III yet provides significantly improved battery life by harnessing sunlight for electric power.
Ascent Solar Technologies closed at $1.61 on Monday.
Shares of Highway Holdings (NASDAQ: HIHO), the Hong Kong-based manufacturer of various components, subassemblies and products for multinational companies, rose 33.33% Monday on 76 times average volume.
Highway Holdings Limited announced Monday its board of directors has declared a cash dividend of $0.03 per share on the company's common stock. The dividend will be paid on October 10, 2012 to shareholders of record on September 1, 2012.
In July the company declared a cash dividend payable on September 10, 2012 to shareholders of record on August 1, 2012
Highway Holdings closed at $0.97 on Monday.
The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment. Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.